Zhong Xiaowei – Trademark Portfolio

Entity Type: 99

Zhong Xiaowei holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RUORD and ENVIRCELL. The owner is based in Puning, Guangdong.

Dabaxu, Daba Town

Puning, Guangdong 515300 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ENVIRCELL
ENVIRCELL
Registered 2024
RUORD
RUORD
Registered 2020

Trademark Classifications

Zhong Xiaowei's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhong Xiaowei have?

Zhong Xiaowei has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Zhong Xiaowei file in?

Zhong Xiaowei files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Zhong Xiaowei's most well-known trademarks?

Zhong Xiaowei's registered trademark portfolio includes well-known marks such as RUORD and ENVIRCELL. These are among 2 currently registered trademarks in the portfolio.

What is Zhong Xiaowei's trademark registration success rate?

Zhong Xiaowei has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.